Vistagen’s on-demand nasal spray could provide a novel option for social anxiety

What could become the first fast-acting drug for social anxiety is working its way through late-stage clinical trials.

Everyday antidepressants are currently the only approved drugs for the condition, but they don’t provide immediate relief from anxiety spikes. Vistagen hopes to offer a better option with its investigational phase 3 drug, fasedienol, which was granted fast track status by the FDA in 2019.